Bicara Therapeutics

About:

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

Website: https://www.bicara.com

Twitter/X: bicaratx

Top Investors: TPG, RA Capital Management, F-Prime Capital, Invus, Deerfield Management

Description:

Bicara Therapeutics is a clinical-stage biotechnology startup focused on developing dual-action biologics. The business is developing bifunctional antibodies that are designed to deliver an immunomodulatory payload directly to the tumor microenvironment, assisting cancer patients in increasing immune cell activity and potentially providing long-term efficacy.